Pfizer and BioNTech have unveiled positive results from their trial conducted on children aged 5 to 11. Their COVID-19 vaccine is “safe,” eliciting a “robust” immune response and is “well-tolerated,” they stated in a press release.
Those aged 12 to 17 have been eligible for the COVID-19 vaccine since June 15th. Currently, 69% of this age group has received a first dose. Faced with the spread of the Delta variant, a question arises: should children under 12 be vaccinated? While the benefits of the COVID-19 vaccine for younger children are still debated, Pfizer and BioNTech have just announced that their vaccine is “safe” for children aged 5 to 11.
0 Comments:
Post a Comment